what is the dosing schedule for retatrutide recommended in adult patients being treated for obesity or weight‑related metabolic disease? Microdosing Retatrutide: Is Splitting Your

February 2, 2026

Para entender su mecanismo es necesario entender qu aporta cada receptor activado: Receptor GLP-1 (GLP-1R): El pptido similar al glucagn tipo 1 acta principalmente en el hipotlamo modulando las seales de saciedad y preferencia energtica

Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control

Specific activation of receptors and modulation by posttranslational modifications of ghrelin can control IRs development in obesity, which is a promising area for research

Further zooming into the impacts of GLP-1 on food consumption, a Morgan Stanley Research report provides interesting early insights on how GLP-1 users eating habits are changing (see figure below)